These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Antiviral agents in the treatment of chronic viral hepatitis. Perrillo RP Prog Liver Dis; 1992; 10():283-309. PubMed ID: 1284255 [No Abstract] [Full Text] [Related]
7. [Liver, biliary tracts and human immunodeficiency virus infection. 1:q liver, HIV and hepatitis B, C and D viruses]. Vuitton DA; Chossegros P; Bresson-Hadni S; Delfraissy JF; Kirn A; Marcellin P; Pol S; Saint-Paul MC Gastroenterol Clin Biol; 1996; 20(3):269-80. PubMed ID: 8763066 [No Abstract] [Full Text] [Related]
8. Management of hepatitis B in special patient populations. Wang HS; Han SH Clin Liver Dis; 2010 Aug; 14(3):505-20. PubMed ID: 20638028 [TBL] [Abstract][Full Text] [Related]
9. [Prophylaxis, Diagnosis and Therapy of Hepatitis-B-Virus-(HBV-)Infection: upgrade of the guideline, AWMF-Register 021/011]. Cornberg M; Protzer U; Dollinger MM; Petersen J; Wedemeyer H; Berg T; Jilg W; Erhardt A; Wirth S; Schirmacher P; Fleig WE; Manns MP Z Gastroenterol; 2007 Jun; 45(6):525-74. PubMed ID: 17554641 [No Abstract] [Full Text] [Related]
10. [Drugs active against hepatitis viruses]. Goudeau A Rev Prat; 1997 Mar; 47(6):640-5. PubMed ID: 9183938 [TBL] [Abstract][Full Text] [Related]
11. [Antiviral preparations in the therapy of chronic viral hepatitis]. Geller LI Ter Arkh; 1990; 62(11):15-9. PubMed ID: 1710074 [TBL] [Abstract][Full Text] [Related]
12. Multiple viral infection as the most common cause of fulminant and subfulminant viral hepatitis in an area endemic for hepatitis B: application and limitations of the polymerase chain reaction. Wu JC; Chen CL; Hou MC; Chen TZ; Lee SD; Lo KJ Hepatology; 1994 Apr; 19(4):836-40. PubMed ID: 8138254 [TBL] [Abstract][Full Text] [Related]
13. Treatment of chronic hepatitis. Lambiase L; Davis GL Gastroenterol Clin North Am; 1992 Sep; 21(3):659-77. PubMed ID: 1381338 [TBL] [Abstract][Full Text] [Related]
14. Tri-infection: successful treatment of a patient infected with HIV and hepatitis B and C viruses--a case report. Johanson F AIDS Read; 2004 Jul; 14(7):389-94. PubMed ID: 15282868 [TBL] [Abstract][Full Text] [Related]
15. Molecular epidemiology of hepatitis B, C and D viruses in Turkish patients. Bozdayi AM; Aslan N; Bozdayi G; Türkyilmaz AR; Sengezer T; Wend U; Erkan O; Aydemir F; Zakirhodjaev S; Orucov S; Bozkaya H; Gerlich W; Karayalçin S; Yurdaydin C; Uzunalimoğlu O Arch Virol; 2004 Nov; 149(11):2115-29. PubMed ID: 15503201 [TBL] [Abstract][Full Text] [Related]
16. [Cytokines and hepatitis]. Degos F Rev Prat; 1993 Mar; 43(5):569-73. PubMed ID: 7688135 [TBL] [Abstract][Full Text] [Related]
17. [Differential hepatitis A, B, C, D and E diagnosis. Clinical, biochemical and viral serologic criteria. 1: Stepwise diagnosis--status of clinical findings]. Eisenburg J Fortschr Med; 1994 Dec; 112(34):501-3. PubMed ID: 7843677 [No Abstract] [Full Text] [Related]
18. Viral hepatitis in 2011: a major step forward. Marcellin P Liver Int; 2011 Jan; 31 Suppl 1():1-2. PubMed ID: 21205130 [No Abstract] [Full Text] [Related]
19. Drug-resistant viral hepatitis. Wright M; Main J; Thomas HC J Infect; 2000 Jul; 41(1):1-4. PubMed ID: 10942634 [No Abstract] [Full Text] [Related]
20. [Current therapy for chronic viral hepatitis. The Viral Hepatitis Panel]. Blum HE; Maier KP; Strohmeyer G Dtsch Med Wochenschr; 1995 Mar; 120(9):295-300. PubMed ID: 7875080 [No Abstract] [Full Text] [Related] [Next] [New Search]